Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Glanbia plc is an Irish multinational nutrition company headquartered in Kilkenny, Ireland, formed in 1997 from the merger of Avonmore Foods and Waterford Foods. It operates through three primary divisions: Glanbia Performance Nutrition, Glanbia Nutritionals, and Joint Ventures, focusing on delivering innovative nutritional solutions for sports, lifestyle, and functional health needs. The Performance Nutrition segment offers a portfolio of consumer brands including Optimum Nutrition, SlimFast, BSN, Isopure, Body&Fit, Nutramino, Amazing Grass, and Think!, providing powders, bars, ready-to-drink beverages, and weight management products sold via retail, online, gyms, and specialty channels. Glanbia Nutritionals specializes in science-led dairy and non-dairy ingredients, such as cheese, proteins, bioactive compounds, premixes, flavors, and functional nutrients for the food, beverage, and health industries. With over 5,700 employees and products distributed in more than 130 countries—primarily North America, Europe, and Asia-Pacific—Glanbia plc plays a pivotal role in the global nutrition market, emphasizing performance, health, and wellness through strategic acquisitions and innovation.
Operating margin is thin at 6.95%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue growth slowed to 2.8%, essentially flat. This is a business that needs a catalyst.
Free cash flow declined 20% versus the prior year, cash generation momentum has weakened.
Profitability & Returns
Revenue (TTM)
$3.95B
▲ +2.8% YoY
Net Income (TTM)
$183M
▲ +11.3% YoY
Op. Margin
6.95%
▲ +0.9pp YoY
ROIC
7.89%
▲ +1.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$284M
▼ -20.3% YoY
Op. Cash Flow (TTM)
$333M
▼ -18.2% YoY
Net Debt
$635M
Cash & Equiv.
$491M
3Y CAGR: -12.8%
3Y CAGR: +5.5%
Continue Research